Comparative Analysis of Regulatory Approaches for Artificial Intelligence Enabled Combination Devices in the United States, Europe, and Japan
Authors:
- 26 August 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 117
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysisDiabetology & Metabolic Syndrome, 2025
- Exploring key stakeholders’ perspectives on integrating the EU AI Act with the MDR for certifying AI medical devicesAI and Ethics, 2024
- Navigating regulatory and policy challenges for AI enabled combination devicesFrontiers in Medical Technology, 2024
- Artificial intelligence-driven transformations in diabetes care: a comprehensive literature reviewAnnals of Medicine & Surgery, 2024